H

Hadassah University Hospital | Hadassah Medical Centre - Hematology Clinical Research

Research site
(Unclaimed)
Location
KALMAN YAAKOV MAN 1, JERUSALEM, Yerushalayim, Israel
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL (EPCORE DLBCL-1)

The drug that will be investigated in the study is an antibody, epcoritamab, also known as EPKINLY™ and GEN3013. Since the safety and tolerability of...

Active, not recruiting
Diffuse Large B-cell Lymphoma
Drug: Investigator's Choice Chemotherapy
Biological: Epcoritamab

The purpose of this study is to determine how participants with metastatic castration-resistant prostate cancer, and evidence of a homologous recombi...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: Abiraterone acetate or Enzalutamide or Docetaxel
Drug: Rucaparib

The purpose of this study is to evaluate the efficacy and safety of pemigatinib versus gemcitabine plus cisplatin chemotherapy in first-line treatmen...

Enrolling
Metastatic Cholangiocarcinoma
Unresectable Cholangiocarcinoma
Drug: Cisplatin
Drug: Gemcitabine

The purpose of this study is to assess the efficacy and safety of of tafasitamab plus lenalidomide in adults with diffuse large B-cell lymphoma (DLBC...

Enrolling
Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Tafasitamab
Drug: Lenalidomide

Trial conditions

B-Cell Lymphoma (2 trials)
Diffuse Large B-Cell Lym... (2 trials)
Lymphoma (2 trials)
Cholangiocarcinoma (1 trial)
Prostatic Cancer (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems